Alzheimer’s disease

Halting the disease progression would lead to great benefits to patients, families and caregivers.

Read more

Parkinson’s disease

The medical need of treatments is high due to the lack of drugs affecting the underlying pathology.

Read more

Complete Spinal Cord Injury

We are developing an innovative treatment that aims to improve the patients’ quality of life.

Read more

Press releases

• March 22, 2019 - Regulatory press releaseBioArctic’s partner Eisai initiates the confirmatory Phase 3 study of BAN2401 in early Alzheimer’s Disease
• March 21, 2019 - Regulatory press releaseBioArctic – Statement regarding today’s trading halt
• March 13, 2019 - Regulatory press releaseBioArctic announces start of Phase 1 study of ABBV-0805 for Parkinson’s disease

Archive

Full Year Report 2018

BioArctic AB published the Full Year Report for the period January – December 2018 on February 14, 2019.

• Report
• Presentation
• Webcast

Read the report

Calendar

• March 26, 2019 - March 31, 2019AD/PD 2019
• April 3, 2019Redeye, Stockholm
• April 9, 2019 - April 10, 2019Swedish-American Life Science Summit, Washington D.C.

All events